COPD

China export industry and global supply chain Cargo airplane flying over logistic containers
Biotech

AirNexis swoops in with $200M series A for COPD asset

AirNexis has inked a deal potentially worth almost $1 billion with a China biopharma, securing rights to a clinical-stage COPD asset.
Gabrielle Masson Jan 9, 2026 11:01am
red and purple piggy banks

Spiro Medical snares $67M series A funding for asthma treatment

Jan 8, 2026 10:50am
Compressor inhaler with childs mask and pocket device for asthmatics on background of table

Roche pens $1B deal for respiratory bispecific from China

Oct 30, 2025 5:04am
Lungs

Study sees COPD patients' breathing boosted by hands-free device

Mar 10, 2023 4:30pm